Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid inflation and weaker consumer spending.
Florida teacher charged with child abuse after throwing shoe at student
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid inflation and weaker consumer spending.
Florida teacher charged with child abuse after throwing shoe at student